HiCardi
MarketedWearable patient monitor that continuously measures ECG and other vital signs; the Korean sales agreement was widened to 12,000 units a year.
FROM PUBLIC EVENTS · 2026-11-15
Commercial · sales Growing supply to Korean hospitals while running trials at US medical institutions. Also seen: Global approvals · expansion
Roles often seen at this stageDevice R&D & support · Sales & marketing · Regulatory affairs
The maker of the HiCardi wearable patient monitor, sold in Korea with a pharmaceutical partner and being trialled at US medical institutions.
Wearable patient monitor that continuously measures ECG and other vital signs; the Korean sales agreement was widened to 12,000 units a year.
Extended its exclusive Korean distribution agreement and set the 2026 contract volume at 12,000 units.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.